Fatty acid-binding protein as marker of muscle injury: experimental findings and clinical application.
Glatz
J F
JF
Cardiovascular Research Institute Maastricht (CARIM), The Netherlands. glatz@fys.unimaas.nl
Van der Vusse
G J
GJ
Maessen
J G
JG
Van Dieijen-Visser
M P
MP
Hermens
W T
WT
D000818:Animals; D015415:Biomarkers / Q000097:blood; D002352:Carrier Proteins / Q000097:blood*; D003402:Creatine Kinase / Q000097:blood; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids / Q000097:blood*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D018482:Muscle, Skeletal / Q000378:metabolism; D018996:Myelin P2 Protein / Q000097:blood*; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis; D017202:Myocardial Ischemia / Q000097:blood / Q000175:diagnosis*; D009206:Myocardium / Q000378:metabolism*; D009211:Myoglobin / Q000097:blood; D009363:Neoplasm Proteins; D012680:Sensitivity and Specificity; D025521:Tumor Suppressor Proteins
D015415:Biomarkers; D002352:Carrier Proteins; C107608:FABP7 protein, human; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D018996:Myelin P2 Protein; D009211:Myoglobin; D009363:Neoplasm Proteins; D025521:Tumor Suppressor Proteins; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase